Skip to main navigation Skip to search Skip to main content

A cyclic phosphonamidate analogue of glucose as a selective inhibitor of inverting glycosidases

  • Stanford University

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Recent work in the synthesis of cyclic phosphonate analogues of glucose [Darrow, J.W.; Drueckhammer, D.G. (1994) J. Org. Chem. 1994, 59, 2976] has been extended to the synthesis of a corresponding phosphonamidate analogue. A phosphonate salt, phosphonate methyl ester, and phosphonamidate analogue were tested as inhibitors of two inverting α-glycosidases, (trehalase and glucoamylase), and two retaining glycosidases, (α-glucosidase and β-glucosidase). No inhibition of any of these enzymes was observed with the phosphonate salt or methyl ester. However, the phosphonamidate gave moderate competitive inhibition of the two inverting glycosidases and the retaining α-glucosidase but no inhibition of β-glucosidase. The phosphonamidate showed enhanced binding relative to a simple monosaccharide only with the inverting glycosidases. This enhanced binding is believed to be due to hydrogen bonding interactions between the phosphonamidate group and two active site carboxylate residues implicated in catalysis. The selectivity toward inverting glycosidases is consistent with differences in distance of an active site carboxylate from the anomeric carbon of the glycoside substrate for the inverting versus the retaining glycosidases.

Original languageEnglish
Pages (from-to)1341-1348
Number of pages8
JournalBioorganic and Medicinal Chemistry
Volume4
Issue number8
DOIs
StatePublished - Aug 1996

Fingerprint

Dive into the research topics of 'A cyclic phosphonamidate analogue of glucose as a selective inhibitor of inverting glycosidases'. Together they form a unique fingerprint.

Cite this